How Gothenburg is powering a biotech pioneer with big ambitions

Gothenburg is playing a key role in the rise of Ribocure Pharmaceuticals, which is pioneering the development of new breakthrough small interfering RNA, siRNA, treatments. The growing biotech company is drawing on the region’s pharmaceutical expertise and dense cluster as it works on therapies for patients with rare and untreatable conditions.